Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors [The Daily D Health Study]
NCT ID: NCT01537809
Last Updated: 2013-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
691 participants
INTERVENTIONAL
2011-06-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
D3 600 IU/ daily
Subjects randomized to 600 IU/day of vitamin D3 taken orally for six months.
Vitamin D3
Subjects are told to take vitamin D daily for 6 months.
Vitamin D3
Subjects are asked to take vitamin D orally, daily for six months.
D3 1000 IU/ daily
Subjects randomized to 1000 IU/day of vitamin D3 taken orally for six months.
Vitamin D3
Subjects are told to take vitamin D daily for 6 months.
Vitamin D3
Subjects are asked to take vitamin D orally, daily for six months.
D3: 2000 IU/daily
Subjects randomized to 2000 IU/day of vitamin D3 taken orally for six months.
Vitamin D3
Subjects are told to take vitamin D daily for 6 months.
Vitamin D3
Subjects are asked to take vitamin D orally, daily for six months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D3
Subjects are told to take vitamin D daily for 6 months.
Vitamin D3
Subjects are asked to take vitamin D orally, daily for six months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must attend school where study is being conducted
* Subject and parent/guardian must give assent/consent to participate in study Related Requirements
* Subjects must complete all study visits (baseline, 3,6 and 12 months)
* Subjects must agree to be blinded
Exclusion Criteria
* Subjects not in 4th-8th grade
* Clinical diagnosis of Cystic Fibrosis
* Clinical diagnosis of Kidney disease
* Subjects currently taking a vitamin D supplement of \>1000 IU/day
* Subjects diagnosed with Irritable Bowel Syndrome (IBS)
* Clinical diagnosis of AIDS
* Clinical diagnosis of Sarcoidosis
* Clinical diagnosis of Epilepsy
9 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Office of Dietary Supplements (ODS)
NIH
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Boston University
OTHER
Boston Children's Hospital
OTHER
Tufts University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Sacheck, PhD
Role: PRINCIPAL_INVESTIGATOR
Tufts University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tufts University
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sacheck J, Goodman E, Chui K, Chomitz V, Must A, Economos C. Vitamin D deficiency, adiposity, and cardiometabolic risk in urban schoolchildren. J Pediatr. 2011 Dec;159(6):945-50. doi: 10.1016/j.jpeds.2011.06.001. Epub 2011 Jul 23.
Sacheck JM, Huang Q, Van Rompay MI, Chomitz VR, Economos CD, Eliasziw M, Gordon CM, Goodman E. Vitamin D supplementation and cardiometabolic risk factors among diverse schoolchildren: a randomized clinical trial. Am J Clin Nutr. 2022 Jan 11;115(1):73-82. doi: 10.1093/ajcn/nqab319.
Blakeley CE, Van Rompay MI, Schultz NS, Sacheck JM. Relationship between muscle strength and dyslipidemia, serum 25(OH)D, and weight status among diverse schoolchildren: a cross-sectional analysis. BMC Pediatr. 2018 Feb 2;18(1):23. doi: 10.1186/s12887-018-0998-x.
Sacheck JM, Van Rompay MI, Chomitz VR, Economos CD, Eliasziw M, Goodman E, Gordon CM, Holick MF. Impact of Three Doses of Vitamin D3 on Serum 25(OH)D Deficiency and Insufficiency in At-Risk Schoolchildren. J Clin Endocrinol Metab. 2017 Dec 1;102(12):4496-4505. doi: 10.1210/jc.2017-01179.
Sawicki CM, Van Rompay MI, Au LE, Gordon CM, Sacheck JM. Sun-Exposed Skin Color Is Associated with Changes in Serum 25-Hydroxyvitamin D in Racially/Ethnically Diverse Children. J Nutr. 2016 Apr;146(4):751-7. doi: 10.3945/jn.115.222505. Epub 2016 Mar 2.
Van Rompay MI, McKeown NM, Goodman E, Eliasziw M, Chomitz VR, Gordon CM, Economos CD, Sacheck JM. Sugar-Sweetened Beverage Intake Is Positively Associated with Baseline Triglyceride Concentrations, and Changes in Intake Are Inversely Associated with Changes in HDL Cholesterol over 12 Months in a Multi-Ethnic Sample of Children. J Nutr. 2015 Oct;145(10):2389-95. doi: 10.3945/jn.115.212662. Epub 2015 Sep 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1103016
Identifier Type: -
Identifier Source: org_study_id